🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to see what dose of 225Ac-lintuzumab is safest...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-02-28
Trial ID
NCT03705858
Treatments Being Tested
This phase I trial studies the side effects and best dose of Actimab-A when...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-12-04
Trial ID
NCT07422363
1. Establish the MTD of Lintuzumab-Ac225 as monotherapy 2. Establish overal...
Status
Terminated
Location
UCLA
Start Date
2016-12
Trial ID
NCT02998047
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of lintuzum...
Status
Suspended
Location
Dana-Farber - Harvard Cancer Center LAO
Start Date
2026-09-03
Trial ID
NCT06888323
This phase I trial tests the safety, side effects, and best dose of lintuzu...
Status
Suspended
Location
Yale University Cancer Center LAO
Start Date
2026-11-18
Trial ID
NCT06802523